Distribution of Ehrlichia canis among military working dogs in the world and selected civilian dogs in the United States.
Antibodies to Ehrlichia canis were detected by indirect immunofluorescence in sera from 233 of 2,077 (11%) military working dogs in various locations throughout the world and from 535 of 938 (57%) civilian dogs in the United States during a 1-year period of study. Overall, E canis infection rates ranged from 13% in the tropical and temperate zones below 45 degrees N to 8% in the cold zone north of 45 degrees N latitude. The highest antibody prevalence rate (24%) was found among a select population of dogs stationed between 40 degrees and 45 degrees north latitude (Japan and Okinawa). The seropositive military dogs did not have clinical signs of ehrlichiosis, thus indicating that the predominant form of infection was subclinical. On the other hand, 216 (23%) of the seropositive civilian dogs had various signs of the disease. The difference was attributed to the fact that the sera from civilian dogs were submitted by practitioners who suspected the disease.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis*; D001208:Asia; D004283:Dog Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology*; D004285:Dogs; D004536:Ehrlichia / Q000276:immunology*; D005060:Europe; D005455:Fluorescent Antibody Technique / Q000662:veterinary; D008891:Military Science; D012287:Rickettsiaceae / Q000276:immunology*; D012288:Rickettsiaceae Infections / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology / Q000662:veterinary*; D013752:Tetracycline / Q000627:therapeutic use; D014481:United States
D000907:Antibodies, Bacterial; D013752:Tetracycline